Salih Cayirمشاهده پروفایل
پژوهشگر ارشد
Salih Cayir, MD, is a Research Fellow at Yale School of Medicine's Department of Psychiatry. His research focuses on neurodegenerative diseases, particularly Parkinson’s disease and frontotemporal dementia, leveraging advanced neuroimaging techniques like PET and MRI. He investigates environmental factors influencing dopamine systems and opioid receptor signaling in addiction. Cayir completed his MD at Istanbul University in 2024 and is engaged in translational research to advance diagnostic and therapeutic approaches for neuropsychiatric disorders. Education: MD from Istanbul University School of Medicine (2024) Research Interests: Combines clinical neurology with imaging science to explore synaptic density (via SV2A imaging), dopamine transporter availability, and environmental health impacts on neurological conditions. His work bridges basic science and clinical practice, aiming to identify biomarkers for early disease detection. Recent Work: Published studies on CSF biomarkers in dementia, socioenvironmental effects on dopamine in Parkinson’s, and κ-opioid receptor roles in addiction. His 2025 travel award supports presenting on synaptic density differences in Parkinson’s patients at the Brain & Brain PET conference. Awards: Early Career Investigator Travel Award (2025) Techniques: PET imaging (including 18F-SynVesT-1, 11C-UCB-J), FDG-PET, structural MRI, and clinical biomarker analysis.






